Management and Outcomes of Hepatoblastoma in Patients With Trisomy 18: A Systematic Review and Pooled Analysis of 70 Patients

Space: StayCurrentMD Author: Ioannis A. Ziogas, Christos D. Kakos, Stamatios Kokkinakis, Jonathan L. Hills-Dunlap, Kristine S. Corkum, Shannon N. Acker, Jose L. Diaz-Miron, Harold N. Lovvorn, Jonathan P. Roach, Ankush Gosain Published:

Author / Expert

Ioannis A. Ziogas, Christos D. Kakos, Stamatios Kokkinakis, Jonathan L. Hills-Dunlap, Kristine S. Corkum, Shannon N. Acker, Jose L. Diaz-Miron, Harold N. Lovvorn, Jonathan P. Roach, Ankush Gosain

Topic overview

Predicted 1-year survival of children with trisomy 18 (T18) has increased to 59.3%. We aimed to systematically review the characteristics, management, and outcomes of children with T18 and hepatoblastoma.

Keywords

Hashtags

0 Views
0 Comments

Comments

Loading comments...